Solara Active Pharma Sciences has informed that the Rights Issue Committee of the Board of Directors by way of Circular Resolution passed today, August 19, 2026, has approved the conversion of 2,79,582 partly paid-up Rights Equity Shares into fully paid-up equity shares of face value of Rs. 10 per equity share of the Company bearing ISIN INE624Z01016 (Converted Rights Equity Shares), comprising: 2,23,051 Rights Equity Shares of face value of Rs.10 each, having Rs. 262.50 paid per share (comprising Rs.7 towards face value and Rs.255.50 towards premium) bearing ISININ9624Z01022, in respect of which the Second and Final Call monies of Rs 112.50 paid per share (comprising Rs.3 towards face value and Rs. 109.5 towards premium) was received; and 56,531 Rights Equity Shares of face value of Rs.10 each, having Rs.131.25 paid per share (comprising Rs.3.50 towards face value and Rs.127.75 towards premium) bearing ISININ9624Z01014, in respect of which the First Call Money and Second and Final Call monies of Rs. 243.75 paid per share (comprising Rs.6.5 towards face value and Rs. 237.25 towards premium) was received.
The above information is a part of company’s filings submitted to BSE.
